286 related articles for article (PubMed ID: 37255929)
1. The ageing immune system as a potential target of senolytics.
Du PY; Gandhi A; Bawa M; Gromala J
Oxf Open Immunol; 2023; 4(1):iqad004. PubMed ID: 37255929
[TBL] [Abstract][Full Text] [Related]
2. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.
Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
FEBS J; 2023 Mar; 290(5):1362-1383. PubMed ID: 35015337
[TBL] [Abstract][Full Text] [Related]
3. Why Senescent Cells Are Resistant to Apoptosis: An Insight for Senolytic Development.
Hu L; Li H; Zi M; Li W; Liu J; Yang Y; Zhou D; Kong QP; Zhang Y; He Y
Front Cell Dev Biol; 2022; 10():822816. PubMed ID: 35252191
[TBL] [Abstract][Full Text] [Related]
4. Insights into targeting cellular senescence with senolytic therapy: The journey from preclinical trials to clinical practice.
Chen P; Wang Y; Zhou B
Mech Ageing Dev; 2024 Apr; 218():111918. PubMed ID: 38401690
[TBL] [Abstract][Full Text] [Related]
5. Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span.
Robbins PD; Jurk D; Khosla S; Kirkland JL; LeBrasseur NK; Miller JD; Passos JF; Pignolo RJ; Tchkonia T; Niedernhofer LJ
Annu Rev Pharmacol Toxicol; 2021 Jan; 61():779-803. PubMed ID: 32997601
[TBL] [Abstract][Full Text] [Related]
6. Cellular Senescence and the Kidney: Potential Therapeutic Targets and Tools.
Knoppert SN; Valentijn FA; Nguyen TQ; Goldschmeding R; Falke LL
Front Pharmacol; 2019; 10():770. PubMed ID: 31354486
[TBL] [Abstract][Full Text] [Related]
7. Senolytic drugs: from discovery to translation.
Kirkland JL; Tchkonia T
J Intern Med; 2020 Nov; 288(5):518-536. PubMed ID: 32686219
[TBL] [Abstract][Full Text] [Related]
8. Targeting Cellular Senescence in Aging and Age-Related Diseases: Challenges, Considerations, and the Emerging Role of Senolytic and Senomorphic Therapies.
Zheng L; He S; Wang H; Li J; Liu Y; Liu S
Aging Dis; 2024 Feb; ():. PubMed ID: 38421832
[TBL] [Abstract][Full Text] [Related]
9. Impact of senolytic treatment on immunity, aging, and disease.
Lorenzo EC; Torrance BL; Haynes L
Front Aging; 2023; 4():1161799. PubMed ID: 37886012
[TBL] [Abstract][Full Text] [Related]
10. Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans.
Zhu Y; Prata LGPL; Gerdes EOW; Netto JME; Pirtskhalava T; Giorgadze N; Tripathi U; Inman CL; Johnson KO; Xue A; Palmer AK; Chen T; Schaefer K; Justice JN; Nambiar AM; Musi N; Kritchevsky SB; Chen J; Khosla S; Jurk D; Schafer MJ; Tchkonia T; Kirkland JL
EBioMedicine; 2022 Mar; 77():103912. PubMed ID: 35292270
[TBL] [Abstract][Full Text] [Related]
11. Senolytic Therapy Enabled by Senescent Cell-Sensitive Biomimetic Melanin Nano-Senolytics.
Zhang H; Xu X; Shou X; Liao W; Jin C; Chen C; Zhang C; Gao W; Zhang J; Ge W; Shi L
Adv Healthc Mater; 2024 May; ():e2401085. PubMed ID: 38796738
[TBL] [Abstract][Full Text] [Related]
12. Short senolytic or senostatic interventions rescue progression of radiation-induced frailty and premature ageing in mice.
Fielder E; Wan T; Alimohammadiha G; Ishaq A; Low E; Weigand BM; Kelly G; Parker C; Griffin B; Jurk D; Korolchuk VI; von Zglinicki T; Miwa S
Elife; 2022 May; 11():. PubMed ID: 35507395
[TBL] [Abstract][Full Text] [Related]
13. The Potential Role and Therapeutic Relevance of Cellular Senescence in Skeletal Pathophysiology.
Li B; Lyu P; Tang J; Li J; Ouchi T; Fan Y; Zhao Z; Li L
J Gerontol A Biol Sci Med Sci; 2024 Apr; 79(4):. PubMed ID: 38306619
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics procedure for investigating senolytic (anti-aging) agents: A digital signal processing technique.
Nwankwo N; Okafor I
Aging Med (Milton); 2023 Dec; 6(4):338-346. PubMed ID: 38239718
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic opportunities for senolysis in cardiovascular disease.
Sweeney M; Cook SA; Gil J
FEBS J; 2023 Mar; 290(5):1235-1255. PubMed ID: 35015342
[TBL] [Abstract][Full Text] [Related]
16. Senolytics and the compression of late-life mortality.
Kowald A; Kirkwood TBL
Exp Gerontol; 2021 Nov; 155():111588. PubMed ID: 34637949
[TBL] [Abstract][Full Text] [Related]
17. Nutrition senolytics - illusion or reality for cognitive ageing?
Chen X; Brodaty H; O'Leary F
Curr Opin Clin Nutr Metab Care; 2022 Jan; 25(1):7-28. PubMed ID: 34812757
[TBL] [Abstract][Full Text] [Related]
18. From the divergence of senescent cell fates to mechanisms and selectivity of senolytic drugs.
L'Hôte V; Mann C; Thuret JY
Open Biol; 2022 Sep; 12(9):220171. PubMed ID: 36128715
[TBL] [Abstract][Full Text] [Related]
19. Senescence and senolytics in cardiovascular disease: Promise and potential pitfalls.
Owens WA; Walaszczyk A; Spyridopoulos I; Dookun E; Richardson GD
Mech Ageing Dev; 2021 Sep; 198():111540. PubMed ID: 34237321
[TBL] [Abstract][Full Text] [Related]
20. A guide to senolytic intervention in neurodegenerative disease.
Lee S; Wang EY; Steinberg AB; Walton CC; Chinta SJ; Andersen JK
Mech Ageing Dev; 2021 Dec; 200():111585. PubMed ID: 34627838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
